OracleBio’s CSO Lorcan Sherry and BDM Mark Anderson, will be attending the Advances in Immuno-oncology Congress, May 12th-13th, in London.
Lorcan Sherry will be delivering a talk entitled; ‘Evaluating And Interpreting Immunotherapy Response Within Tumour Tissue’, which will discuss current understanding of immune cell relationships within the tumour microenvironment, how quantifying immune/inflammatory cells within tumor tissue via histology combined with digital image analysis can help guide and have an impact on R&D decision making and describe recent advances and future perspectives in evaluating immune cell spatial context within the tumour microenvironment.
We will also have an exhibitor booth in the networking area on both days and look forward to meeting you there to discuss how OracleBio can support your oncology projects using detailed quantitative image analysis.
OracleBio offers a range of digital pathology image analysis services to support pre-clinical and clinical Pharmaceutical R&D studies. If you would like to learn more about OracleBio’s serivces, or wish to arrange a time to speak to Lorcan or Mark during the congress, please contact us.